About
Purinomia is a clinical-stage biotechnology company focusing on developing innovative therapeutics to treat cancer and inflammatory diseases. We have built a robust, proprietary pipeline of breakthrough therapies to target these high unmet needs, including the clinical-stage program PUR001 and 3 pre-clinical programs
PUR002, PUR003, and PUR004.
Mission
We aspire to leverage our deep understanding of tumor biology and pathophysiology of inflammatory diseases; as well as the novel mechanisms of action of our pipeline products, to translate into target biology, develop biomarkers and strategically select indications and patients for clinical studies.
Founders
Yan Wu
Simon Robson
Simon Robson
CEO & Scientific Founder
Simon Robson
Simon Robson
Simon Robson
Scientific Founder
Haitao Zhao
Simon Robson
Haitao Zhao
Scientific Founder